Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | ICMT | O60725 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1016635 | 0.82 | — | — | |
| SCHEMBL7529589 | 0.79 | NOS1 (0.48) | NOS1ICMTKMT2AMAPTMEN1 | |
| SCHEMBL1016494 | 0.78 | — | — | |
| SCHEMBL87750 | 0.76 | — | — | |
| SCHEMBL28405493 | 0.76 | ICMT (0.41) | NOS1ICMTKMT2AMAPTMEN1 | |
| SCHEMBL3791171 | 0.76 | ICMT (0.71) | ICMTKMT2AMAPTMEN1TRPA1 | |
| SCHEMBL122097 | 0.76 | MAPT (0.67) | NOS1ICMTKMT2AMAPTMEN1 | |
| SCHEMBL2879944 | 0.74 | ICMT (0.75) | ICMTKMT2AMAPTMEN1TRPA1 | |
| SCHEMBL25434106 | 0.73 | NOS1 (0.44) | NOS1ICMTKMT2ATRPA1CYP3A4 | |
| SCHEMBL1017648 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12098350-B2 | Sulfur-containing volatile organic compounds in cannabis | ABX INVESTMENTS, INC. (US) | 2024-09-24 | — | — | US | claimed |
| US-20240090545-A1 | CITRUS MODIFIER COMPOUNDS IN CANNABIS | ABSTRAX TECH INC (US) | 2024-03-21 | — | — | US | claimed |
| WO-2024054529-A1 | CITRUS MODIFIER COMPOUNDS IN CANNABIS | ABSTRAX TECH INC. (US) | 2024-03-14 | — | — | WO | claimed |
| WO-2023213483-A1 | DETERMINATION OF THE PRESENCE OF GASEOUS SULPHUR-CONTAINING COMPOUNDS IN THE EXHALED AIR OF VEHICLE OCCUPANTS | ZF FRIEDRICHSHAFEN AG (DE) | 2023-11-09 | — | — | WO | claimed |
| US-11725160-B2 | Sulfur-containing volatile organic compounds in cannabis | ABX INVESTMENTS, INC. (US) | 2023-08-15 | — | — | US | claimed |
| US-20220098510-A1 | SULFUR-CONTAINING VOLATILE ORGANIC COMPOUNDS IN CANNABIS | ABX INVESTMENTS, INC. | 2022-03-31 | — | — | US | claimed |
| US-11214757-B2 | Sulfur-containing volatile organic compounds in cannabis | ABX INVESTMENTS, INC. (US) | 2022-01-04 | — | — | US | claimed |
| US-20210253976-A1 | SULFUR-CONTAINING VOLATILE ORGANIC COMPOUNDS IN CANNABIS | ABX INVESTMENTS, INC. | 2021-08-19 | — | — | US | claimed |
| US-20210251268-A1 | SULFUR-CONTAINING VOLATILE ORGANIC COMPOUNDS IN CANNABIS | ABX INVESTMENTS, INC. | 2021-08-19 | — | — | US | claimed |
| WO-2026102053-A1 | FOAM ENHANCING PHOSPHOLIPID EMULSION SYSTEMS | ABSTRAX TECH INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026102051-A1 | METHOD AND SYSTEM FOR STABILIZING EMULSIONS USING VITAMINS AND VITAMINS SALTS | ABSTRAX TECH INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260123640-A1 | METHOD AND SYSTEM FOR STABILIZING EMULSIONS USING VITAMINS AND VITAMINS SALTS | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260125625-A1 | HOPS ACIDS STABILIZED EMULSIONS | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260123653-A1 | Foam Enhancing Phospholipid Emulsion Systems | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2001062719-A1 | SELECTIVE OXIDATION OF SULFIDES BY THE USE OF AN OXIDANT SYSTEM CONSISTING OF LITHIUM MOLIBDENATE NIOBATE AND HYDROGEN PEROXIDE | KOO SANGHO (KR) | 2001-08-30 | — | — | WO | disclosed |
| EP-0785782-A1 | DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY | Allergan (US) | 1997-07-30 | — | — | EP | disclosed |
| US-5512683-A | OSTEOPOROSIS, IMMUNOSUPPRESSANT | HOFFMANN-LA ROCHE INC. (US) | 1996-04-30 | — | — | US | disclosed |
| WO-1996011686-A1 | DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY | ALLERGAN (US) | 1996-04-25 | — | — | WO | disclosed |
| US-5391766-A | Antiarthritic agents for rheumatoid, immunosuppressants; treating psoriasis, autoimmune diseases | HOFFMANN-LA ROCHE INC. (US) | 1995-02-21 | — | — | US | disclosed |
| US-4175043-A | LUBRICANTS | MOBIL OIL CORPORATION (US) | 1979-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125625-A1 | HOPS ACIDS STABILIZED EMULSIONS | HAO2, NIPSNAP1, AP2S1 | NOS1 1926/4885ICMT 1967/4885KMT2A 4163/4885 |
| US-20260123640-A1 | METHOD AND SYSTEM FOR STABILIZING EMULSIONS USING VITAMINS AND VITAMINS SALTS | TTPA, PROC, ADH7 | NOS1 2435/4885ICMT 647/4885KMT2A 2399/4885 |
| US-20260123653-A1 | Foam Enhancing Phospholipid Emulsion Systems | PHOSPHO1, PLTP, PLIN3 | NOS1 1643/4885ICMT 2150/4885KMT2A 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.